B-2067

N/A

Report date: 2023/05/11 13:42:25

Base Information

Drug NameB-2067
Drug Alias NameB-2067
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionComplement system proteins inhibitors
TargetsComplement system proteins
Therapy Area/IndicationsNeuromyelitis Optica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Tasly Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Tasly Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeuromyelitis Optica
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A